Menu

Monte Rosa Therapeutics, Inc. GLUE

Full chart Compare
Set alert

Price alert · GLUE

All alert types
10.58 USD +0.01 (+0.09%)

At closeNov 9, 2026, 4:01 PM EST

10.58 0.00 0.00%

After hours · Nov 9, 4:01 PM ET

10.28 Day range 10.83
9.68 52-week range 25.77
YTD
-32.53%
1 year
-14.05%

Revenue & Expenses

Other Income → Expenses: $14.48MExpenses → Selling, General & Admin: $36.38MExpenses → Research & Development: $141.50MIncome Tax Benefit → Expenses: $1.10MGross Profit → Expenses: $123.67MRevenue → Gross Profit: $123.67MNet Loss → Expenses: $38.63MOther Income$14.48MIncome Tax Benefit$1.10MGross Profit$123.67MNet Loss$38.63MExpenses$177.88MSelling, General & Admin$36.38MResearch & Development$141.50MRevenue$123.67M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

GLUE annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
123.67M75.62M000
123.67M75.62M000
123.67M75.62M000
177.88M156.73M143.31M112.38M72.88M
141.50M121.56M111.27M85.06M57.16M
36.38M35.17M32.04M27.32M15.73M
-54.21M-81.11M-143.31M-112.38M-72.88M
-1.10M2.57M338.00K00
-38.63M-72.70M-135.35M-108.50M-73.96M
-38.63M-72.70M-135.35M-108.50M-73.96M
-38.63M-72.70M-135.35M-108.50M-73.96M
-38.63M-72.70M-135.35M-108.50M-73.96M
-0.46-0.98-2.63-2.30-2.96
-0.46-0.98-2.63-2.30-2.96
-0.46-0.98-2.63-2.30-2.96
-39.72M-70.13M-135.01M-108.50M-73.96M
-39.72M-70.13M-135.01M-108.50M-73.96M
83.07M73.91M51.40M47.23M25.00M
83.07M73.91M51.40M47.23M25.00M